Objective: Combined hyperlipidaemia is a common and highly atherogenic lipid phenotype with multiple lipoprotein abnormalities that are difficult to normalise with single-drug therapy. The ATOMIX ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Objective: In order to assess the long-term (12 months) efficacy and safety of fenofibrate administered with simvastatin in the treatment of primary mixed hyperlipidaemia, we conducted a study ...

Hyperlipidaemia was identified through self-reported data, cholesterol ≥6.21 mmol/L or taking stains and other ...

For example, a person previously considered free of all of the 20 conditions who was diagnosed with hyperlipidaemia, hypertension and depression during one visit was counted as having three incident ...

induce hyperlipidaemia 120. Jun N-terminal kinases (JNKs) could be involved in activation of the transcription factor AP-1, which is activated in asthmatic airways, and small-molecule inhibitors ...

Objective To test the hypothesis that gouty arthritis (gout) is a risk factor for incidence of heart failure and for echocardiographic measures signifying subclinical heart failure. Design Post-hoc, ...

Figure 3. Fatty acid elongation by the ELOVL family of enzymes. Diagram of the four-step fatty acid elongation cycle indicating the mammalian (ALL CAPITALS) and the yeast enzymes involved in each step ...

Diabetic nephropathy (DN) is the most common chronic kidney disease. Accumulation of glucose and metabolites activates resident macrophages in kidneys. Resident macrophages play diverse roles on ...

Definition. The Type IV lipoprotein pattern is the hallmark of endogenous hyperlipemia. It implies that glycerides synthesized in the body, usually in the liver, have been excreted into plasma at ...

In comparison, the non-COVID-19 cohort was comprised of 45 women and 33 men with mean±SD age of 45.5±13.3 years. Comorbidities in the COVID-19 cohort included hypertension, hyperlipidaemia, diabetes ...